British HIV Association guidelines on the management of opportunistic infection in people living with HIV : The clinical investigation and management of pyrexia of unknown origin 2023
2023; Wiley; Volume: 24; Issue: S4 Linguagem: Inglês
10.1111/hiv.13558
ISSN1468-1293
AutoresClare L. van Halsema, Christopher P. Eades, Victor J. Johnston, Robert F. Miller,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoHIV MedicineVolume 24, Issue S4 p. 3-18 SUPPLEMENT ARTICLE British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023 C. L. van Halsema, C. L. van Halsema Regional infectious diseases unit, Manchester University NHS Foundation TrustSearch for more papers by this authorC. P. Eades, C. P. Eades Regional infectious diseases unit, Manchester University NHS Foundation Trust University of ManchesterSearch for more papers by this authorV. J. Johnston, V. J. Johnston London School of Hygiene & Tropical Medicine Hospital for Tropical Diseases, University College London Hospitals NHS Foundation TrustSearch for more papers by this authorR. F. Miller, R. F. Miller London School of Hygiene & Tropical Medicine Institute for Global Health, University College London Central & North West London NHS Foundation TrustSearch for more papers by this author C. L. van Halsema, C. L. van Halsema Regional infectious diseases unit, Manchester University NHS Foundation TrustSearch for more papers by this authorC. P. Eades, C. P. Eades Regional infectious diseases unit, Manchester University NHS Foundation Trust University of ManchesterSearch for more papers by this authorV. J. Johnston, V. J. Johnston London School of Hygiene & Tropical Medicine Hospital for Tropical Diseases, University College London Hospitals NHS Foundation TrustSearch for more papers by this authorR. F. Miller, R. F. Miller London School of Hygiene & Tropical Medicine Institute for Global Health, University College London Central & North West London NHS Foundation TrustSearch for more papers by this author First published: 13 November 2023 https://doi.org/10.1111/hiv.13558Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Fernandez C, Beeching NJ. Pyrexia of unknown origin. Clin Med. 2018; 18: 170-174. 2Mulders-Manders CM, Simon A, Bleeker-Rovers C. Fever of unknown origin. Clin Med. 2015; 15: 280-284. 3Varghese GM, Trowbridge P, Doherty T. Investigating and managing pyrexia of unknown origin in adults. BMJ. 2010; 341: C5470. 4Kirwan PD, Amin-Chowdhury Z, Croxford SE, et al. Invasive pneumococcal disease in people with human immunodeficiency virus in England, 1999-2017. Clin Infect Dis. 2021; 73: 91-100. 5Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PloS One. 2012; 7:e34156. 6Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961; 40: 1-30. 7Durack DT, Street AC. Fever of unknown origin–reexamined and redefined. Curr Clin Top Infect Dis. 1991; 11: 35-51. 8Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003; 253: 263-275. 9Lozano F, Torre-Cisneros J, Santos J, et al. Impact of highly active antiretroviral therapy on fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002; 21: 137-139. 10Abellán-Martínez J, Guerra-Vales J-M, Fernández-Cotarelo M-J, González-Alegre M-T. Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (highly active antiretroviral therapy). Eur J Intern Med. 2009; 20: 474-477. 11Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review. BMC Infect Dis. 2019; 19: 653. 12Armstrong WS, Katz JT, Kazanjian PH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999; 28: 341-345. 13 Public Health England. HIV in the UK: towards zero HIV transmissions by 2030. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/965765/HIV_in_the_UK_2019_towards_zero_HIV_transmissions_by_2030.pdf (accessed January 2022). 14Nelson M, Dockrell D, Edwards S. BHIVA Guidelines Subcommittee. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011; 12(Suppl 2): 1-140. 15Pareek M, Christina Greenaway C, Noori T, et al. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016; 14: 48. 16Gupta RK, Rice B, Brown AE, et al. Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland. Lancet HIV. 2015; 2: e243-e251. 17van Halsema CL, Okhai H, Hill T, Sabin CA, UK Collaborative HIV Cohort (UK CHIC) Study. Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom. AIDS. 2020; 34: 1813-1821. 18 Public Health England. Shooting up: infections among people who inject drugs. 2021 update. Available at: https://www.gov.uk/government/publications/shooting-up-infections-among-people-who-inject-drugs-in-the-uk (accessed September 2021). 19 Public Health England. Imported fever service (IFS). 2014. Available at: https://www.gov.uk/guidance/imported-fever-service-ifs (accessed September 2021). 20Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015; 42: 328-354. 21 The Royal College of Radiologists, Royal College of Physicians of London, Royal College of Physicians and Surgeons of Glasgow, Royal College of Physicians of Edinburgh, British Nuclear Medicine Society, Administration of Radioactive Substances Advisory Committee. Evidence-based indications for the use of PET-CT in the UK. 2016. Available at: https://www.rcr.ac.uk/sites/default/files/publication/bfcr163_pet-ct.pdf (accessed September 2023). 22Haroon A, Zumla A, Bomanji J. Role of fluorine 18fluorodeoxyglucose positron emission tomography computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012; 54: 1333-1341. 23Barucha T, Rutherford A, Skeoch S, et al. the FDG-PET/CT in fever of unknown origin working group. Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise. Clin Radiol. 2017; 72: 764-771. 24Jain L, Mackenzie S, Bomanji JB, et al. 18F-Fluorodeoxyglucose positron emission tomography-computed tomography imaging in HIV-infected patients with lymphadenopathy, with or without fever and/or splenomegaly. Int J STD AIDS. 2018; 29: 691-694. 25Martin C, Castaigne C, Tondeur M, Flamen P, de Wit S. Role and interpretation of fluorodeoxyglcose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study. HIV Med. 2013; 14: 455-462. 26Castaigne C, Tondeur M, De Wit S, et al. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun. 2009; 30: 41-47. 27Kubota K, Nakamoto Y, Tamaki N, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med. 2011; 25: 355-364. 28Pereira AMV, Husmann L, Sah B-R, Battegay E, Franzen D. Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun. 2016; 37: 57-65. 29Brown M. Pyrexia of unknown origin 90 years on: a paradigm of modern clinical medicine. Postgrad Med J. 2015; 91: 665-669. 30Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003; 163: 545-551. 31Santos ES, Raez LE, Eckardt P, DeCesare T, Whitcomb CC, Byrne GE Jr. The utility of a bone marrow biopsy in diagnosing the source of fever of unknown origin in patients with AIDS. J Acquir Immune Defic Syndr. 2004; 37: 1599-1603. 32Brook MG, Ayles H, Harrison C, Rowntree C, Miller RF. Diagnostic utility of bone marrow sampling in HIV positive patients. Genitourin Med. 1997; 73: 117-121. 33Llewelyn MJ, Noursadeghi M, Dogan A, et al. Diagnostic utility of bone marrow sampling in HIV-infected patients since the advent of highly active antiretroviral therapy. Int J STD AIDS. 2005; 16: 686-690. 34Quesada AE, Tholpady A, Wanger A, Nguyen AND, Chen L. Utility of bone marrow examination for workup of fever of unknown origin in patients with HIV/AIDS. J Clin Pathol. 2015; 68: 241-245. 35Lozano F, Torre-Cisneros J, Bascuñana A, et al. Grupo Anduluz para el Estudio de las Enfermedades Infecciosas. Prospective evaluation of fever of unknown origin in patients infected with the human immmunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1996; 15: 705-711. 36Benito N, Núñez A, de Górgolas M, et al. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1997; 157: 1577-1580. 37Fernández-Avilés F, Ribera JM, Romeu J, et al. The usefulness of the bone marrow examination in the etiological diagnosis of prolonged fever in patients with HIV infection. Med Clin (Barc). 1999; 112: 641-645. 38Pande A, Bhattacharyya M, Pain S, Ghosh A, Samanta A. Diagnostic yield of bone marrow examination in HIV associated FUO in ART naïve patients. J Infect Public Health. 2010; 3: 124-129. 39Labrador J, Pérez-López E, Martin A, et al. Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10-year single-centre experience. Intern Med J. 2014; 44: 610-612. 40Engels E, Marks PW, Kazanjian P. Usefulness of bone marrow examination in the evaluation of unexplained fevers in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995; 21: 427-428. 41Moualed D, Robinson M, Qureishi A, Gurr P. Cervical tuberculous lymphadenitis: diagnosis and demographics, a five-year case series in the UK. Ann R Coll Surg Eng. 2018; 100: 392-396. 42Muyanja D, Kalyesubula R, Namukwaya E, Othieno E, Mayanja-Kizza H. Diagnostic accuracy of fine needle aspiration cytology in providing a diagnosis of cervical lymphadenopathy among HIV-infected patients. Afr Health Sci. 2015; 15: 107-116. 43Meghji S, Giddings CE. What is the optimal diagnostic pathway in tuberculous lymphadenitis in the face of increasing resistance: Cytology or histology? Am J Otolaryngol. 2015; 36: 781-785. 44 National Institute for Health and Care Excellence. Tuberculosis [NG33]. 2019. Available at: https://www.nice.org.uk/guidance/ng33 (accessed September 2021). 45Prego V, Glatt AE, Roy V, Thelmo W, Dincsoy H, Raufman JP. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Int Med. 1990; 150: 333-336. 46Wiboonchutikul S, Manosuthi W, Kowadisaiburana B, Sungkanuparph S. Diagnostic value of percutaneous liver biopsy in fever of unkown origin in patients with human immunodeficiency virus infection. Jpn J Infect Dis. 2015; 68: 296-300. 47Shavadia J, Mwanzi S, Rana F, Twahir M. Utility of liver biopsy in HIV-infected patients presenting with febrile illnesses and inconclusive evaluation. East Afr Med J. 2008; 85: 505-508. 48García-Ordóñez MA, Colmerero JD, Jiménez-Oñate F, et al. Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin. J Infect. 1999; 38: 94-98. 49Chang YG, Chen PJ, Hung CC, et al. Opportunistic hepatic infections in AIDS patients with fever of unknown origin. J Formos Med Assoc. 1999; 1: 5-10. 50Roger PM, Mondain V, Saint Paul MC, et al. Liver biopsy is not useful in the diagnosis of mycobacterial infections in patients who are infected with human immunodeficiency virus. Clin Infect Dis. 1996; 23: 1302-1304. 51Bissuel F, Leport C, Perronne C, et al. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med. 1994; 236: 529-535. 52Cappell MS, Schwartz MS, Biempica L. Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med. 1990; 88: 123-130. 53Kennedy M, O'Reilly M, Bergin CJ, McDonald GS. Liver biopsy pathology in human immunodeficiency virus infection. Eur J Gastroenterol Hepatol. 1998; 10: 255-258. 54Gordon SC, Veneri RJ, McFadden RF, et al. Major hemorrhage after percutaneous liver biopsy in patients with AIDS. Gastroenterology. 1991; 100: 1787. 55Churchill DR, Mann D, Coker RJ, et al. Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med. 1996; 72: 62-64. 56Kitkungvan D, Apisarnthanarak A, Plengpart P, Mundy LM. Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS. 2008; 19: 232-235. 57Bravo AA, Sheth S, Chopra S. Liver biopsy. N Engl J Med. 2001; 344: 495-500. 58Waters L, Winston A, Reeves I, et al. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022. HIV Med. 2022; 23(Suppl 5): 3-115. 59Bracchi M, van Halsema C, Post F, et al. British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019. HIV Med. 2019; 20(Suppl 6): s2-s83. 60 World Health Organization. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. 2021. Available at: https://www.who.int/publications/i/item/9789240022232 (accessed September 2021). 61Haddow LJ, Easterbrook PJ, Mosam A, et al. Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis. 2009; 49: 1424-1432. 62Meintjes G, Lawn SD, Scano F, et al. International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008; 8: 516-523. 63Haddow LJ, Colebunders R, Meintjes G, et al. International Network for the Study of HIV-associated IRIS (INSHI). Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010; 10: 791-802. 64Miller RF, Hingorani AD, Foley NM. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS. 1996; 7: 170-173. 65Mohle-Boetani JC, Koehler JE, Berger TG, et al. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis. 1996; 22: 794-800. 66Miralles P, Moreno S, Pérez-Tascón M, et al. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995; 20: 872-875. 67Knobel H, Supevía A, Salvadó M, et al. [Fever of unknown origin in patients with human immunodeficiency virus infection. Study of 100 cases]. In Spanish. Rev Clin Esp. 1996; 196: 349-353. 68Barbado FJ, Gómez-Cerezo J, Peña JM, et al. Fever of unknown origin: classic and associated with human immunodeficiency virus infection. A comparative study. J Med. 2001; 32: 152-162. 69Genné D, Chave JP, Glauser MP. [Fever of unknown origin in a cohort of HIV-positive patients]. In French. Schweiz Med Wochenschr. 1992; 122: 1797-1802. 70Bhagat SK, Kekre NS, Gopalakrishnan G, Balaji V, Mathews MS. Changing profile of prostatic abscess. Int Braz J Urol. 2008; 34: 164-170. 71Riera M, Altés J, Homar F, et al. Fever of unknown origin in patients with HIV infection. Enferm Infec Microbiol Clin. 1996; 14: 581-585. 72Carbonell-Biot C, Ena Muñoz J, Pasquau Liaño F, et al. Fever of unknown origin in patients infected with the human immunodeficiency virus. Rev Clin Esp. 1996; 196: 4-8. 73Lambertucci JR, Rayes AA, Nunes F, et al. Fever of undetermined origin in patients with the acquired immunodeficiency syndrome in Brazil: report on 55 cases. Rev Inst Med Trop Sao Paulo. 1999; 41: 27-32. 74Kitkungvan D, Apisarnthanarak A, Plengpart P, Mundy LM. Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS. 2008; 19: 232-235. 75Karabela ŞN, Kart YK. Fever of unknown origin: evaluation of 110 classical and HIV-associated cases in the last decade. Hosp Pract (1995). 2022; 50: 222-227. 76Soto-Pérez-de-Celis E, López-Quiñones Llamas JM, Berra A. A rare case of disseminated pyomyositis in an African immigrant with HIV and chronic hepatitis B. Infect Dis Clin Pract. 2005; 13: 321-323. 77Bernabeu-Wittel M, Villanueva JL, Pachón J, et al. Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever. Eur J Clin Micro Infect Dis. 1999; 18: 324-329. 78Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis. 1994; 18: 358-363. 79Allen S, Nelson M. Pyrexia of unknown origin in HIV infection and the resurgence of syphilis. Int J STD AIDS. 2002; 13: 860. 80Setianingrum F, Riina Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019; 57: 133-150. 81Yoo SD-J, Worodria W, Davis JL, et al. The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda. AIDS. 2010; 54: 269-274. 82Abdulla R, Savva A, Ahmed Z. An unusual chest infection in an English HIV patient returning from Thailand. HIV Med. 2011; 12 Suppl 1: 57. Abstract P127. Available at. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1468-1293.2011.00925.x accessed October 2021. 83Fernandez-Guerrero ML. Dealing with fever of unknown origin in an HIV-infected patient. AIDS Patient Care STDS. 1998; 12: 673-676. 84Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore). 2006; 85: 22-36. 85Falagas ME, Klempner MS. Babesios in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996; 22: 908-912. 86Albrecht H, Skörde J, Arasteh K, et al. Disseminated toxoplasmosis in AIDS patients–report of 16 cases. Scand J Infect Dis. 1995; 27: 71-74. 87Pineda JA, Gallardo JA, J Macías J et al. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998; 36: 2419–2422. 88Mylona EE, Baraboutis IG, Lekakiset LJ, et al. Multicentric Castleman's disease in HIV infection: a systematic review of the literature. AIDS Rev. 2008; 10: 25-35. 89Akenroye AT, Madan N, Mohammadi F, Leider J. Hemophagocytic lymphohistiocytosis mimics many common conditions: case series and review of literature. Eur Ann Allergy Clin Imunol. 2017; 49: 31-41. 90Bedimo RJ, Geisler WM. Phenytoin hypersensitivity syndrome masquerading as fever and systemic illness of unknown origin in an HIV-infected patient. Int J STD AIDS. 2005; 16: 178-179. 91Bartlett JG, Sullivan M, Feinberg J. Fever of unknown origin in patients infected with human immunodeficiency virus. Infect Dis Clin Pract. 1996; 5: 412-420. 92Friedman ND, Spelman DW. Subacute thyroiditis presenting as pyrexia of unknown origin in a patient with human immunodeficiency virus infection. Clin Infect Dis. 1999; 29: 1352-1353. 93Hasson H, Nozza S, Mantelli B, Biswas P, Lazzarin A, Beretta A. A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresis. AIDS. 2006; 20: 312-313. 94Howling SJ, Shaw PJ, Miller RF. Acute pulmonary embolism in patients with HIV disease. Sex Transm Infect. 1999; 75: 25-29. 95Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016; 27: 421-446. 96Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS. 2020; 31: 4-15. 97Nwokolo NC, Dragovic B, Patel S, Tong CYW, Barker G, Radcliffe K. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016; 27: 251-267. REFERENCES 1Knobel H, Supevía A, Salvadó M, et al. [Fever of unknown origin in patients with human immunodeficiency virus infection. Study of 100 cases]. In Spanish. Rev Clin Esp. 1996; 196: 349-353. 2Lozano F, Torre-Cisneros J, Bascuñana A, et al.; the Grupo Anduluz para el Estudio de las Enfermedades Infecciosas. Prospective evaluation of fever of unknown origin in patients infected with the human immmunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1996; 15: 705-711. 3Miller RF, Hingorani AD, Foley NM. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS. 1996; 7: 170-173. 4Lambertucci JR, Rayes AA, Nunes F, et al. Fever of undetermined origin in patients with the acquired immunodeficiency syndrome in Brazil: report on 55 cases. Rev Inst Med Trop Sao Paulo. 1999; 41: 27-32. 5Barbado FJ, Gómez-Cerezo J, Peña JM, et al. Fever of unknown origin: classic and associated with human immunodeficiency virus infection. A comparative study. J Med. 2001; 32: 152-162. 6Abellán-Martínez J, Guerra-Vales J-M, Fernández-Cotarelo M-J, González-Alegre M-T. Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (highly active antiretroviral therapy). Eur J Intern Med. 2009; 20: 474-477. REFERENCES 1Genné D, Chave JP, Glauser MP. [Fever of unknown origin in a cohort of HIV-positive patients]. In French. Schweiz Med Wochenschr. 1992; 122: 1797-1802. 2Bissuel F, Leport C, Perronne C, et al. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med. 1994; 236: 529-535. 3Miralles P, Moreno S, Pérez-Tascón M, et al. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995; 20: 872-875. 4Miller RF, Hingorani AD, Foley NM. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS. 1996; 7: 170-173. 5Lozano F, Torre-Cisneros J, Bascuñana A, et al.; the Grupo Anduluz para el Estudio de las Enfermedades Infecciosas. Prospective evaluation of fever of unknown origin in patients infected with the human immmunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1996; 15: 705-711. 6Knobel H, Supevía A, Salvadó M, et al. [Fever of unknown origin in patients with human immunodeficiency virus infection. Study of 100 cases]. In Spanish. Rev Clin Esp. 1996; 196: 349-353. 7Riera M, Altés J, Homar F, et al. [Fever of unknown origin in patients with HIV infection]. In Spanish. Enferm Infecc Microbiol Clin. 1996; 14: 581-585. 8Carbonell Biot C, Ena Muñoz J, Pasquau Liaño F, Badía Ferrando P, Ortiz de Salazar Martín A, Vilar Zanón A. [Fever of unknown origin in patients infected with the human immunodeficiency virus]. In Spanish. Rev Clin Esp. 1996; 196: 4-8. 9Armstrong WS, Katz JT, Kazanjian PH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999; 28: 341-345. 10Lambertucci JR, Rayes AA, Nunes F, et al. Fever of undetermined origin in patients with the acquired immunodeficiency syndrome in Brazil: report on 55 cases. Rev Inst Med Trop Sao Paulo. 1999; 41: 27-32. 11Barbado FJ, Gómez-Cerezo J, Peña JM, et al. Fever of unknown origin: classic and associated with human immunodeficiency virus infection. A comparative study. J Med. 2001; 32: 152-162. 12Santos ES, Raez LE, Eckardt P, DeCesare T, Whitcomb CC, Byrne GE Jr. The utility of a bone marrow biopsy in diagnosing the source of fever of unknown origin in patients with AIDS. J Acquir Immune Defic Syndr. 2004; 37: 1599-1603. 13Kitkungvan D, Apisarnthanarak A, Plengpart P, Mundy LM. Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS. 2008; 19: 232-235. 14Karabela ŞN, Kart YK. Fever of unknown origin: evaluation of 110 classical and HIV-associated cases in the last decade. Hosp Pract (1995). 2022; 50: 222-227. Volume24, IssueS4Supplement: British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023November 2023Pages 3-18 ReferencesRelatedInformation
Referência(s)